Relative Mitochondrial Priming Predicts Survival in Older AML Patients Treated Intensively-Reference-Cited by-同舟云学术

Relative Mitochondrial Priming Predicts Survival in Older AML Patients Treated Intensively

Published:2022-12-19 Issue:1 Volume:7 Page:e819
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Dal Bello Reinaldo,Pacchiardi Kim,Chauvel Clémentine,Adès Lionel,Braun Thorsten,Pasanisi Justine,Fournier Elise,Berthon Céline,Clappier Emmanuelle,Raffoux Emmanuel,Lebon Delphine,Cluzeau Thomas,Roumier Christophe,Plesa Adriana,Celli-Lebras Karine,Dombret Hervé,Preudhomme Claude,Mathis Stéphanie,Puissant Alexandre,Gardin Claude,Itzykson Raphael

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference6 articles.

1. Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML.;Vo;Cell,2012

2. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.;Dohner;Blood,2017

3. Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results.;Gardin;Blood Adv,2020

4. Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy.;Itzykson;Blood,2021

5. Functional precision oncology: testing tumors with drugs to identify vulnerabilities and novel combinations.;Letai;Cancer Cell,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel precision medicine approaches and treatment strategies in hematological malignancies;Journal of Internal Medicine;2023-08-07

2. Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors;Cancers;2023-07-06